Russell Frank Company’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$315K Buy
+3,399
New +$339K ﹤0.01% 2594
2015
Q4
Sell
-92
Closed -$14K 3068
2015
Q3
$14K Sell
92
-2,055
-96% -$1.51M ﹤0.01% 2974
2015
Q2
$2.04M Sell
2,147
-1,045
-33% -$854K ﹤0.01% 1957
2015
Q1
$2.34M Sell
3,192
-1,149
-26% -$863K ﹤0.01% 1684
2014
Q4
$3.47M Sell
4,341
-1,154
-21% -$621K 0.01% 1496
2014
Q3
$2.19M Buy
+5,495
New +$1.47M ﹤0.01% 1691
2013
Q4
Sell
-3
Closed -$1K 3178
2013
Q3
$1K Buy
+3
New +$524 ﹤0.01% 3413

Other funds holding TTPH

Russell Frank Company's TTPH Position: Q1 2016 in Review

Russell Frank Company opened a new position in Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2016: 3,399 shares worth $315K. The stake represents ﹤0.01% of the portfolio and ranks #2594 among its holdings. This is a return to the name: Russell Frank Company previously reported a position in TTPH as recently as Q3 2015.

Russell Frank Company first reported a position in TTPH in Q3 2013 and has held it in 7 quarters since. The position peaked at $3.47M in Q4 2014. 101 funds tracked by Wall St. Rank hold TTPH as of Q1 2016.

  • Russell Frank Company held 3,399 shares of Tetraphase Pharmaceuticals, Inc. worth $315K as of Q1 2016.
  • Tetraphase Pharmaceuticals, Inc. was a new Russell Frank Company position in Q1 2016.
  • Tetraphase Pharmaceuticals, Inc. made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2594 holding.
  • Russell Frank Company first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2013 and has held it in 7 quarters since.
  • Russell Frank Company's Tetraphase Pharmaceuticals, Inc. position peaked at $3.47M in Q4 2014.
  • 101 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.